Suppr超能文献

[数字医学技术在肝胆胰外科的应用:20年回顾与展望]

[Application of digital medical technology in hepatopancreatobiliary surgery:20 years' retrospective review and prospect].

作者信息

Fang C H, Tian J, Zhang P, Yee Y Y, Zhong S Z

机构信息

First Department of Hepatobiliary Surgery, Institution for Digital Intelligence,Zhujiang Hospital,Southern Medical University,Guangdong Provincial Clinical and Engineering Center of Digital Medicine,Guangzhou 510282,China.

Key Laboratory of Molecular Imaging,Chinese Academy of Sciences,Beijing 100190,China.

出版信息

Zhonghua Wai Ke Za Zhi. 2021 Oct 1;59(10):807-811. doi: 10.3760/cma.j.cn112139-20210405-00159.

Abstract

Digital medicine has played a vital role in promoting the development of hepatobiliary and pancreatic surgery of China.The multidisciplinary integration of medical science and technology innovates research and development,and practice in clinical diagnosis and treatment.Digital medicine has enabled within 20 years,development from digital virtual human,three-dimensional visualization,molecular fluorescence imaging to artificial intelligence.There are four important stages of the development in China's digital medical technology:digital medicine 1.0 (2002 to 2004,digital virtual human) on digital human anatomy, digital medicine 2.0(2004 to 2014,three-dimensional(3D) visualization and 3D printing) on 3D diagnosis and treatment of complex hepatobiliary and pancreatic diseases, digital medicine 3.0(2014 to 2019,molecular fluorescence imaging) on precision navigation of tumor boundaries and micro tumors using indocyanine green molecular imaging, and digital medicine 4.0(2019 to present,digital artificial intelligence) on augmented reality-based and mixed reality-based 3D abdominal navigation hepatectomy and photoacoustic imaging of tumors.Over the past 20 years' course of development,Chinese researchers have made countless and remarkable achievements in digital medicine through continuous efforts and innovation. In the future,cutting-edge technologies such as artificial intelligence on deep machine learning,multi-mode image real-time fusion navigation surgery,photoacoustic imaging and targeted molecular probe technology will promote the development of digital medicine 4.0 in a coordinated manner,leading to the advent of digital medicine 5.0.

摘要

数字医学在中国肝胆胰外科发展中发挥了至关重要的作用。医学与科技的多学科融合在临床诊疗的研发及实践方面实现了创新。数字医学在20年间实现了从数字虚拟人、三维可视化、分子荧光成像到人工智能的发展。中国数字医学技术的发展有四个重要阶段:数字医学1.0(2002年至2004年,数字虚拟人)聚焦数字人体解剖学;数字医学2.0(2004年至2014年,三维(3D)可视化与3D打印)用于复杂肝胆胰疾病的3D诊断与治疗;数字医学3.0(2014年至2019年,分子荧光成像)借助吲哚菁绿分子成像实现肿瘤边界及微小肿瘤的精准导航;数字医学4.0(2019年至今,数字人工智能)用于基于增强现实和混合现实的3D腹部导航肝切除术及肿瘤光声成像。在过去20年的发展历程中,中国研究人员通过持续努力与创新在数字医学领域取得了无数卓越成就。未来,诸如基于深度机器学习的人工智能、多模态图像实时融合导航手术、光声成像及靶向分子探针技术等前沿技术将协同推动数字医学4.0的发展,引领数字医学5.0的到来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验